Novelix Pharmaceuticals Ltd — Important, 10-07-2026: Company Update

The company's board has approved the allotment of 33.75 lakh equity shares at Rs. 20 each to promoter and promoter group members by converting warrants, raising 5.06 Cr. Additionally, 12 lakh equity shares were allotted at Rs. 57 each to non-promoter investors through a preferential issue, raising 6.84 Cr. These allotments collectively increase the company's paid-up equity capital from 23.90 Cr to 28.47 Cr, reflecting capital expansion and fundraising efforts.